 WATERTOWN, Mass., May 17, 2022 GLOBE NEWSWIRE -- EyePoint Pharmaceuticals, Inc. NASDAQ: EYPT, a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that Nancy Lurker, Chief Executive Officer of EyePoint Pharmaceuticals, will present at the H.C Wainwright Global Healthcare Investment Conference. The presentation will be available for on-demand viewing starting Tuesday, May 24, 2022 at 9:00 a.m. ET. 